T&R Biofab Co., Ltd. (KOSDAQ:246710)

T&R Biofab Statistics

Total Valuation

T&R Biofab has a market cap or net worth of KRW 153.65 billion. The enterprise value is 196.40 billion.

Market Cap	153.65B
Enterprise Value	196.40B

Important Dates

The next estimated earnings date is Tuesday, March 17, 2026.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	n/a

Share Statistics

T&R Biofab has 47.57 million shares outstanding. The number of shares has increased by 1.58% in one year.

Current Share Class	47.57M
Shares Outstanding	47.57M
Shares Change (YoY)	+1.58%
Shares Change (QoQ)	+25.24%
Owned by Insiders (%)	15.08%
Owned by Institutions (%)	2.79%
Float	40.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.43
PB Ratio	10.78
P/TBV Ratio	14.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-20.45
EV / Sales	9.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.84

Financial Position

The company has a current ratio of 0.46, with a Debt / Equity ratio of 3.18.

Current Ratio	0.46
Quick Ratio	0.24
Debt / Equity	3.18
Debt / EBITDA	n/a
Debt / FCF	-3.89
Interest Coverage	-2,705.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-19.83%
Weighted Average Cost of Capital (WACC)	5.27%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.92% in the last 52 weeks. The beta is 0.47, so T&R Biofab's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-5.92%
50-Day Moving Average	3,155.80
200-Day Moving Average	3,045.41
Relative Strength Index (RSI)	44.15
Average Volume (20 Days)	1,152,991

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T&R Biofab had revenue of KRW 20.67 billion and -9.61 billion in losses. Loss per share was -371.66.

Revenue	20.67B
Gross Profit	5.25B
Operating Income	-9.37B
Pretax Income	-9.61B
Net Income	-9.61B
EBITDA	-5.35B
EBIT	-9.37B
Loss Per Share	-371.66

Balance Sheet

The company has 5.57 billion in cash and 45.37 billion in debt, with a net cash position of -39.80 billion or -836.70 per share.

Cash & Cash Equivalents	5.57B
Total Debt	45.37B
Net Cash	-39.80B
Net Cash Per Share	-836.70
Equity (Book Value)	14.26B
Book Value Per Share	524.68
Working Capital	-19.92B

Cash Flow

In the last 12 months, operating cash flow was -9.58 billion and capital expenditures -2.08 billion, giving a free cash flow of -11.66 billion.

Operating Cash Flow	-9.58B
Capital Expenditures	-2.08B
Free Cash Flow	-11.66B
FCF Per Share	-245.17

Margins

Gross margin is 25.39%, with operating and profit margins of -45.33% and -46.46%.

Gross Margin	25.39%
Operating Margin	-45.33%
Pretax Margin	-46.46%
Profit Margin	-46.46%
EBITDA Margin	-25.87%
EBIT Margin	-45.33%
FCF Margin	n/a

Dividends & Yields

T&R Biofab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.58%
Shareholder Yield	-1.58%
Earnings Yield	-6.25%
FCF Yield	-7.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 29, 2025. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 29, 2025
Split Type	Forward
Split Ratio	1.2

Scores

T&R Biofab has an Altman Z-Score of -2.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.13
Piotroski F-Score	2